Esomeprazole and omeprazole could increase the serum concentrations of benzodiazepines (via CYP2C19 inhibition) bringing about improved adverse effects such as drowsiness, although the scientific relevance is low in many clients – keep track of the individual for adverse effects (e. If client are unable to resume their regular oral medication https://medeusresearchchem.com/shop/